Skip to Main Content

Author Details

Marc R Birtwistle
Clemson University.
2007
69
24
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37461453Increasing Signal Intensity of Fluorescent Oligo-Labeled Antibodies to Enable Combination Multiplexing.bioRxiv2024
37461453Increasing Signal Intensity of Fluorescent Oligo-Labeled Antibodies to Enable Combination Multiplexing.bioRxiv2024
37101545Predicting individual-specific cardiotoxicity responses induced by tyrosine kinase inhibitors.Front Pharmacol2023
37414767MOBILE pipeline enables identification of context-specific networks and regulatory mechanisms.Nat Commun2023
37020976Computational speed-up of large-scale, single-cell model simulations via a fully integrated SBML-based format.Bioinform Adv2023
37126527Predicting anti-cancer drug combination responses with a temporal cell state network model.PLoS Comput Biol2023
37441358Modeling the Dynamics of Eukaryotic DNA Synthesis in Remembrance of Tunde Ogunnaike.Ind Eng Chem Res2023
37101545Predicting individual-specific cardiotoxicity responses induced by tyrosine kinase inhibitors.Front Pharmacol2023
37126527Predicting anti-cancer drug combination responses with a temporal cell state network model.PLoS Comput Biol2023
37020976Computational speed-up of large-scale, single-cell model simulations via a fully integrated SBML-based format.Bioinform Adv2023
37414767MOBILE pipeline enables identification of context-specific networks and regulatory mechanisms.Nat Commun2023
37441358Modeling the Dynamics of Eukaryotic DNA Synthesis in Remembrance of Tunde Ogunnaike.Ind Eng Chem Res2023
34657158Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor verteporfin in preclinical glioblastoma models.Neuro Oncol2022
36302844Relating individual cell division events to single-cell ERK and Akt activity time courses.Sci Rep2022
36207580A multi-omic analysis of MCF10A cells provides a resource for integrative assessment of ligand-mediated molecular and phenotypic responses.Commun Biol2022
35926160Method for Improved Fluorescence Corrections for Molar Mass Characterization by Multiangle Light Scattering.Biomacromolecules2022
35729113A scalable, open-source implementation of a large-scale mechanistic model for single cell proliferation and death signaling.Nat Commun2022
36316338Network inference from perturbation time course data.NPJ Syst Biol Appl2022
36656607CellTrackVis: analyzing the performance of cell tracking algorithms.Eurograph IEEE VGTC Symp Vis2022
35189161Leveraging modeling and simulation to optimize the therapeutic window for epigenetic modifier drugs.Pharmacol Ther2022
34657158Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor verteporfin in preclinical glioblastoma models.Neuro Oncol2022
35181749Author Correction: Cell fate decisions are specified by the dynamic ERK interactome.Nat Cell Biol2022
35058449Proteomic cellular signatures of kinase inhibitor-induced cardiotoxicity.Sci Data2022
35729113A scalable, open-source implementation of a large-scale mechanistic model for single cell proliferation and death signaling.Nat Commun2022
36656607CellTrackVis: analyzing the performance of cell tracking algorithms.Eurograph IEEE VGTC Symp Vis2022
36207580A multi-omic analysis of MCF10A cells provides a resource for integrative assessment of ligand-mediated molecular and phenotypic responses.Commun Biol2022
36302844Relating individual cell division events to single-cell ERK and Akt activity time courses.Sci Rep2022
35926160Method for Improved Fluorescence Corrections for Molar Mass Characterization by Multiangle Light Scattering.Biomacromolecules2022
36316338Network inference from perturbation time course data.NPJ Syst Biol Appl2022
35189161Leveraging modeling and simulation to optimize the therapeutic window for epigenetic modifier drugs.Pharmacol Ther2022
35181749Author Correction: Cell fate decisions are specified by the dynamic ERK interactome.Nat Cell Biol2022
35058449Proteomic cellular signatures of kinase inhibitor-induced cardiotoxicity.Sci Data2022
34009954Protocol for Creating Antibodies with Complex Fluorescence Spectra.Bioconjug Chem2021
34179955SysMod: the ISCB community for data-driven computational modelling and multi-scale analysis of biological systems.Bioinformatics2021
34009954Protocol for Creating Antibodies with Complex Fluorescence Spectra.Bioconjug Chem2021
33941686Protein structure-based gene expression signatures.Proc Natl Acad Sci U S A2021
34739849A library of induced pluripotent stem cells from clinically well-characterized, diverse healthy human individuals.Stem Cell Reports2021
34739849A library of induced pluripotent stem cells from clinically well-characterized, diverse healthy human individuals.Stem Cell Reports2021
33941686Protein structure-based gene expression signatures.Proc Natl Acad Sci U S A2021
34179955SysMod: the ISCB community for data-driven computational modelling and multi-scale analysis of biological systems.Bioinformatics2021
32968055Transcriptomic profiling of human cardiac cells predicts protein kinase inhibitor-associated cardiotoxicity.Nat Commun2020
31729169Predicting In Vivo Efficacy from In Vitro Data: Quantitative Systems Pharmacology Modeling for an Epigenetic Modifier Drug in Cancer.Clin Transl Sci2020
32968055Transcriptomic profiling of human cardiac cells predicts protein kinase inhibitor-associated cardiotoxicity.Nat Commun2020
31729169Predicting In Vivo Efficacy from In Vitro Data: Quantitative Systems Pharmacology Modeling for an Epigenetic Modifier Drug in Cancer.Clin Transl Sci2020
30899020Mitochondrial origins of fractional control in regulated cell death.Nat Commun2019
31302153A Multi-center Study on the Reproducibility of Drug-Response Assays in Mammalian Cell Lines.Cell Syst2019
31434897Wilm's tumor 1 promotes memory flexibility.Nat Commun2019
30899020Mitochondrial origins of fractional control in regulated cell death.Nat Commun2019
31302153A Multi-center Study on the Reproducibility of Drug-Response Assays in Mammalian Cell Lines.Cell Syst2019
31434897Wilm's tumor 1 promotes memory flexibility.Nat Commun2019
  • 1 - 50 of 138

Recommended Authors

Aurelien Dugourd
Institute of Experimental Medicine and Systems Biology, RWTH Aachen University
Career Start Year 2016
Number of shared co-authors 4
Elana J Fertig
Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 6
Matt Thomson
California Institute of Technology
Career Start Year 2009
Number of shared co-authors 0
Neda Bagheri
University of Washington
Career Start Year 2007
Number of shared co-authors 0
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 4
Jacob Stewart-Ornstein
Hillman Cancer Center, University of Pittsburgh School of Medicine
Career Start Year 2005
Number of shared co-authors 1
Armand Bankhead
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year 2005
Number of shared co-authors 1
Adam A Margolin
Icahn School of Medicine
Career Start Year 2004
Number of shared co-authors 7
Amina A Qutub
University of Texas at San Antonio
Career Start Year 2004
Number of shared co-authors 5
Terence P Speed
Walter and Eliza Hall Institute of Medical Research
Career Start Year 2003
Number of shared co-authors 4
Rune Linding
Humboldt-Universitat zu Berlin
Career Start Year 2002
Number of shared co-authors 2
Steven J Altschuler
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 2001
Number of shared co-authors 2
Kevin A Janes
University of Virginia
Career Start Year 2001
Number of shared co-authors 3
Lani F Wu
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 2001
Number of shared co-authors 2
Ilya Shmulevich
Institute for Systems Biology
Career Start Year 2001
Number of shared co-authors 2
Mariano J Alvarez
Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center
Career Start Year 2000
Number of shared co-authors 9
Dana Pe'er
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 3
Harish Shankaran
Merck & Co.
Career Start Year 2000
Number of shared co-authors 0
Tero Aittokallio
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Career Start Year 1999
Number of shared co-authors 7
Kerby Shedden
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 1
Wolfgang Huber
Technische Universitat Munchen
Career Start Year 1995
Number of shared co-authors 1
David de Graaf
Syntimmune Inc.
Career Start Year 1995
Number of shared co-authors 2
Roland Eils
Berlin Institute of Health (BIH) and Charite
Career Start Year 1995
Number of shared co-authors 1
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 7
Jesper Tegn??r
King Abdullah University of Science and Technology (KAUST)
Career Start Year 1993
Number of shared co-authors 3
Andrea Califano
Columbia University
Career Start Year 1993
Number of shared co-authors 13
Fabian J Theis
Technical University of Munich
Career Start Year 1992
Number of shared co-authors 1
Zolt??n N Oltvai
University of Rochester
Career Start Year 1991
Number of shared co-authors 0
Yuval Kluger
Yale University School of Medicine
Career Start Year 1984
Number of shared co-authors 2
Douglas A Lauffenburger
Massachusetts Institute of Technology
Career Start Year 1979
Number of shared co-authors 5

Collaborators

Mehdi Bouhaddou
J. David Gladstone Institutes
Co-authored papers 12
Ravi Iyengar
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers 10
Evren U Azeloglu
Co-authored papers 9
Eric A Sobie
Co-authored papers 8
Jens Hansen
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
James M Gallo
Co-authored papers 6
Gomathi Jayaraman
Co-authored papers 5
Laura M Heiser
Oregon Health Sciences University
Co-authored papers 5
Cemal Erdem
Co-authored papers 4
Dušica VidoviĿ
Co-authored papers 4
Sean Gross
Co-authored papers 4
Stephan C Sch??rer
Institute for Data Science and Computing, University of Miami
Co-authored papers 4
Rick J Koch
Co-authored papers 3
Joe W Gray
Oregon Health and Science University
Co-authored papers 3
Peter K Sorger
Co-authored papers 3
Caitlin E Mills
Co-authored papers 3
James E Korkola
Co-authored papers 3
Joseph Goldfarb
Co-authored papers 3
Nikos Tzavaras
Co-authored papers 2
Antje-Christine Walz
Roche Pharma Research and Early Development, F. Hoffmann-La Roche Ltd.
Co-authored papers 2
Malvina Papanastasiou
Co-authored papers 2
Phillip Buckhaults
University of South Carolina
Co-authored papers 2
Albert Lee
Co-authored papers 2
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 2
Jie Wu
Co-authored papers 2
Denis Torre
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Henrik Molina
Co-authored papers 2
Rafael Dariolli
Co-authored papers 2
Mario Niepel
Co-authored papers 2
Nicole C Dubois
Co-authored papers 2
Release 1.2